tert-butyl 6-hydroxy-1H-benzo[d]imidazole-1-carboxylate | 943772-77-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: tert-butyl 6-hydroxy-1H-benzo[d]imidazole-1-carboxylate
• 英文别名: 6-hydroxy-benzoimidazole-1-carboxylic acid tert-butyl ester；1-tert-butoxycarbonyl-6-hydroxybenzimidazole；Tert-butyl 6-hydroxybenzimidazole-1-carboxylate
• CAS: 943772-77-8
• 化学式: C₁₂H₁₄N₂O₃
• 分子量: 234.255
• InChiKey: RSDVPMNYCRZLCN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  64.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  tert-butyl 6-hydroxy-1H-benzo[d]imidazole-1-carboxylate 在 盐酸 、 TEA 、 氨 、 sodium hydride 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 7-{6-[1-(1-Imino-ethyl)-piperidin-4-yloxy]-benzoimidazol-1-ylmethyl}-naphthalene-2-carboxamidine
  参考文献：
  名称：

  Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors

  摘要：

  Inhibitors based on the benzimidazole scaffold showed subnanomolar potency against Factor Xa with 500-1000-fold selectivity against thrombin and 50-100-fold selectivity against trypsin. The 2-substituent on the benzimidazole ring had a strong impact on the FXa inhibitory activity. Crystallography studies suggest that the 2-substituent may have a conformational effect favoring the extended binding conformation. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00139-6
• 作为产物：
  描述：

  二碳酸二叔丁酯 、 1H-苯并咪唑-5-醇 生成 tert-butyl 6-hydroxy-1H-benzo[d]imidazole-1-carboxylate
  参考文献：
  名称：

  Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors

  摘要：

  Inhibitors based on the benzimidazole scaffold showed subnanomolar potency against Factor Xa with 500-1000-fold selectivity against thrombin and 50-100-fold selectivity against trypsin. The 2-substituent on the benzimidazole ring had a strong impact on the FXa inhibitory activity. Crystallography studies suggest that the 2-substituent may have a conformational effect favoring the extended binding conformation. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00139-6

文献信息

• BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
  申请人：Global Blood Therapeutics, Inc.

  公开号：US20150259296A1

  公开（公告）日：2015-09-17

  Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

  本文提供了适用作为血红蛋白调节剂的化合物和药物组合物，它们的制备方法和中间体，以及在治疗由血红蛋白介导的疾病和需要组织和/或细胞氧合的疾病中使用它们的方法。
• WO2007/76034
  申请人：——

  公开号：——

  公开（公告）日：——
• NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ANTICOAGULANTS
  申请人：BERLEX LABORATORIES, INC.

  公开号：EP0865281B1

  公开（公告）日：2002-04-03
• US5849759A
  申请人：——

  公开号：US5849759A

  公开（公告）日：1998-12-15
• US9802900B2
  申请人：——

  公开号：US9802900B2

  公开（公告）日：2017-10-31